Identifying risk of poor pain outcomes to steer patients to early interventions and avoid opioid overuse

Identifying risk of poor pain outcomes to steer patients to early interventions and avoid opioid overuse retrieved 20 March 2024 from https://medicalxpress.com/news/2024-03-poor-pain-outcomes-patients-early.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.55 minutes ago22 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

'Junk DNA' no more: Investigators develop method of identifying cancers from repeat elements of genetic codeRepeats of DNA sequences, often referred to as 'junk DNA' or 'dark matter,' that are found in chromosomes and could contribute to cancer or other diseases have been challenging to identify and characterize.
Source: medical_xpress - 🏆 101. / 51 Read more »

Machine learning classifier reduces the time to identify personalized tumor reactive T cell receptorsMaking a personalized T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have shown that the laborious first step of identifying tumor-reactive T cell receptors for patients can be replaced with a machine learning classifier that...
Source: NewsMedical - 🏆 19. / 71 Read more »

Machine learning classifier accelerates the development of cellular immunotherapiesMaking a personalized T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have shown that the laborious first step of identifying tumor-reactive T cell receptors for patients can be replaced with a machine learning classifier that...
Source: medical_xpress - 🏆 101. / 51 Read more »